BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32414201)

  • 1. LXRα Regulates ChREBPα Transactivity in a Target Gene-Specific Manner through an Agonist-Modulated LBD-LID Interaction.
    Fan Q; Nørgaard RC; Grytten I; Ness CM; Lucas C; Vekterud K; Soedling H; Matthews J; Lemma RB; Gabrielsen OS; Bindesbøll C; Ulven SM; Nebb HI; Grønning-Wang LM; Sæther T
    Cells; 2020 May; 9(5):. PubMed ID: 32414201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity.
    Bindesbøll C; Fan Q; Nørgaard RC; MacPherson L; Ruan HB; Wu J; Pedersen TÅ; Steffensen KR; Yang X; Matthews J; Mandrup S; Nebb HI; Grønning-Wang LM
    J Lipid Res; 2015 Apr; 56(4):771-85. PubMed ID: 25724563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LXRα Regulates Hepatic ChREBPα Activity and Lipogenesis upon Glucose, but Not Fructose Feeding in Mice.
    Fan Q; Nørgaard RC; Bindesbøll C; Lucas C; Dalen KT; Babaie E; Itkonen HM; Matthews J; Nebb HI; Grønning-Wang LM
    Nutrients; 2017 Jun; 9(7):. PubMed ID: 28661453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.
    Cha JY; Repa JJ
    J Biol Chem; 2007 Jan; 282(1):743-51. PubMed ID: 17107947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormone receptor beta (TRbeta) and liver X receptor (LXR) regulate carbohydrate-response element-binding protein (ChREBP) expression in a tissue-selective manner.
    Gauthier K; Billon C; Bissler M; Beylot M; Lobaccaro JM; Vanacker JM; Samarut J
    J Biol Chem; 2010 Sep; 285(36):28156-63. PubMed ID: 20615868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver.
    Denechaud PD; Bossard P; Lobaccaro JM; Millatt L; Staels B; Girard J; Postic C
    J Clin Invest; 2008 Mar; 118(3):956-64. PubMed ID: 18292813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT6 controls hepatic lipogenesis by suppressing LXR, ChREBP, and SREBP1.
    Zhu C; Huang M; Kim HG; Chowdhury K; Gao J; Liu S; Wan J; Wei L; Dong XC
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166249. PubMed ID: 34425214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of MIG12 as a mediator for stimulation of lipogenesis by LXR activation.
    Inoue J; Yamasaki K; Ikeuchi E; Satoh S; Fujiwara Y; Nishimaki-Mogami T; Shimizu M; Sato R
    Mol Endocrinol; 2011 Jun; 25(6):995-1005. PubMed ID: 21474539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDB1 E3 ligase controls dietary fructose-induced ChREBPα stabilization and liver steatosis via CRY1.
    Tong X; Zhang D; Shabandri O; Oh J; Jin E; Stamper K; Yang M; Zhao Z; Yin L
    Metabolism; 2020 Jun; 107():154222. PubMed ID: 32246987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ChREBP and LXRα mediate synergistically lipogenesis induced by glucose in porcine adipocytes.
    Zhang GH; Lu JX; Chen Y; Guo PH; Qiao ZL; Feng RF; Chen SE; Bai JL; Huo SD; Ma ZR
    Gene; 2015 Jul; 565(1):30-8. PubMed ID: 25827716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.
    Lin YN; Wang CCN; Chang HY; Chu FY; Hsu YA; Cheng WK; Ma WC; Chen CJ; Wan L; Lim YP
    J Agric Food Chem; 2018 Nov; 66(44):11647-11662. PubMed ID: 30359008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of LXRα, ChREBP and Elovl6 in liver and white adipose tissue on medium- and long-chain fatty acid diet-induced insulin resistance.
    Sun H; Jiang T; Wang S; He B; Zhang Y; Piao D; Yu C; Wu N; Han P
    Diabetes Res Clin Pract; 2013 Dec; 102(3):183-92. PubMed ID: 24262945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioneer factor Foxa2 enables ligand-dependent activation of type II nuclear receptors FXR and LXRα.
    Kain J; Wei X; Reddy NA; Price AJ; Woods C; Bochkis IM
    Mol Metab; 2021 Nov; 53():101291. PubMed ID: 34246806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome.
    Iizuka K; Horikawa Y
    Endocr J; 2008 Aug; 55(4):617-24. PubMed ID: 18490833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRα.
    Zhong D; Zhang Y; Zeng YJ; Gao M; Wu GZ; Hu CJ; Huang G; He FT
    Lipids Health Dis; 2013 Mar; 12():32. PubMed ID: 23496987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-regulation of hepatic glucose metabolism via ChREBP and nuclear receptors.
    Poupeau A; Postic C
    Biochim Biophys Acta; 2011 Aug; 1812(8):995-1006. PubMed ID: 21453770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the ChREBPβ Isoform Is Essential for Glucose-Stimulated β-Cell Proliferation.
    Zhang P; Kumar A; Katz LS; Li L; Paulynice M; Herman MA; Scott DK
    Diabetes; 2015 Dec; 64(12):4158-70. PubMed ID: 26384380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice.
    Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G
    J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue Specific Effects of Dietary Carbohydrates and Obesity on ChREBPα and ChREBPβ Expression.
    Stamatikos AD; da Silva RP; Lewis JT; Douglas DN; Kneteman NM; Jacobs RL; Paton CM
    Lipids; 2016 Jan; 51(1):95-104. PubMed ID: 26526060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ChREBP downregulates SNAT2 amino acid transporter expression through interactions with SMRT in response to a high-carbohydrate diet.
    Velázquez-Villegas L; Noriega LG; López-Barradas AM; Tobon-Cornejo S; Méndez-García AL; Tovar AR; Torres N; Ortiz-Ortega VM
    Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E102-E112. PubMed ID: 33225719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.